TDP-43 pathology has been found in all types of ALS patients excluding patients with FUS and SOD1 mutations where instead, aggregates of the respective mutated proteins accumulate (Masrori and Van Damme, 2020; Shatunov and Al-Chalabi, 2021). Here, TARDBP is linked to amyotrophic lateral sclerosis.